Add Yahoo as a preferred source to see more of our stories on Google. Ever since the United Nations cultural organization recognized the Haiti and the Dominican Republic’s indigenous cassava flatbread ...

In our series of letters from African journalists, Ghanaian Elizabeth Ohene considers the call of Uganda's President Yoweri Museveni for people to eat the humble cassava as the price of wheat soars ...

Cassava Sciences is laying off 10 employees—a third of its workforce—as the biotech seeks to conserve cash in the wake of the phase 3 fail of its lead Alzheimer’s disease drug. The RETHINK-ALZ trial ...

Cassava, known as shimul alu in Bangladesh, is a root vegetable widely consumed in many countries across the globe for its dietary benefits, which include healthy carbohydrates and vitamin C. It is ...

Add Yahoo as a preferred source to see more of our stories on Google. You may have noticed more products being sold that contain cassava, a starchy vegetable used in many parts of the world. But a new ...

Small Alzheimer’s disease biotech Cassava Sciences is defending its work after a citizen petition filed with the FDA questioned the scientific integrity of the company's clinical trials for simufilam ...

Cassava Sciences is imploding — and as it crumbles, a dark, ugly corner of the Alzheimer’s disease world is being exposed and will hopefully get cleaned up. Remi Barbier, Cassava’s longtime CEO, has ...

The biotech is paying $40 million not to acquire a drug or fund a development program, but to satisfy a regulator. The money is going toward a settlement with the Securities and Exchange Commission.

This article has been updated with information from a company conference call, share price movement, and comments from a Seeking Alpha analyst. Cassava Sciences (NASDAQ:SAVA) said it recorded a $40M ...